Last updated: April 2026
Related: Wondering why tirzepatide works differently than semaglutide? Read GIP vs GLP-1: what the dual-agonist difference means for weight loss.
If you’re paying out of pocket for tirzepatide, the cost varies dramatically depending on how you access it — from roughly $250 per month on the low end of cash-pay compounded programs to well over $1,200 per month for brand-name Zepbound or Mounjaro at retail.
This guide breaks down what tirzepatide actually costs in 2026, why pricing varies so much across access paths, and how to figure out which option makes sense for your situation. If you’ve been priced out of Zepbound or Mounjaro at the pharmacy counter, you’re not alone — and you have more options than you might realize.
What is tirzepatide?
Tirzepatide is a dual GLP-1/GIP receptor agonist. That means it activates two metabolic pathways at once: GLP-1, which most weight-loss medications target, and GIP, which adds a second mechanism for regulating appetite, blood sugar, and fat metabolism.
It was developed and patented by Eli Lilly and is sold under two brand names:
- Zepbound — FDA-approved for chronic weight management in adults with obesity, or in adults with overweight plus at least one weight-related condition
- Mounjaro — FDA-approved for type 2 diabetes
Both are FDA-approved finished drug products manufactured by Eli Lilly, with labels and dosing schedules set by the FDA. The two brands target different conditions but use the same active molecule at the same dose strengths.
If you’re also weighing semaglutide as an option, we cover that in our semaglutide vs. Wegovy guide.
Brand-name tirzepatide cost in 2026
If you walk into a pharmacy without insurance and try to fill a Zepbound or Mounjaro prescription, here’s what you can expect to pay.
Zepbound cash price
Zepbound’s list price is roughly $1,060 per month through retail pharmacies for the standard injectable pen. Eli Lilly also offers Zepbound through their direct-to-consumer pharmacy, LillyDirect, in a single-dose vial format at around $349 to $499 per month depending on dose. The vial format requires you to draw and inject from a vial rather than using a pre-filled pen.
Mounjaro cash price
Mounjaro typically runs $1,100 or more per month at retail pharmacies without insurance. It’s not generally available through LillyDirect’s discounted vial program, so the cash-pay path for Mounjaro is more limited than for Zepbound.
Manufacturer savings cards
Eli Lilly offers savings cards for both medications, but the meaningful discounts are restricted:
- Commercial insurance with coverage: You may pay as little as $25 per month
- Commercial insurance without coverage: You may pay around $650 per month
- No insurance, Medicare, or Medicaid: You generally do not qualify for the savings card
This last point is the catch. Most people searching “tirzepatide cost without insurance” are exactly the people the manufacturer savings cards exclude.
Why brand-name tirzepatide is priced this way
The short answer is that Eli Lilly holds the patent and the U.S. drug pricing system allows manufacturers to set cash-pay prices well above what most other countries pay. A few factors drive list pricing:
- Patent protection runs through the early 2030s, so there is no generic competition.
- Pharmacy benefit managers (PBMs) negotiate rebates that lower prices for insured patients but generally don’t pass through to cash-pay customers.
- Manufacturing, distribution, and pharmacy markups add to the retail price at every stage of the supply chain.
- R&D recovery and shareholder returns are built into the list price.
The cumulative effect is that without insurance, Americans paying cash can pay several times what insured patients with savings card discounts pay for the same finished drug product.
Compounded tirzepatide as a cash-pay option
Compounded tirzepatide is a different category of preparation entirely. It is not a pre-approved finished drug product. Instead, it is prepared by a state-licensed 503A compounding pharmacy under state pharmacy board oversight, pursuant to a patient-specific prescription issued by a licensed clinician following clinical evaluation.
Pharmaceutical compounding is a long-standing, federally recognized practice that allows pharmacists to prepare customized medications when a commercially manufactured product is unavailable, on the FDA’s drug shortage list, or otherwise not appropriate for a specific patient. The governing framework — Section 503A of the federal Food, Drug, and Cosmetic Act — sets which active ingredients may be compounded, who may prescribe them, and the standards (including USP chapters on sterility and quality) the preparing pharmacy must meet.
Compounded tirzepatide is not FDA-approved as a finished drug product. It is regulated through licensure and inspection of the compounding pharmacy, not through FDA pre-market product approval. This is a meaningful regulatory distinction patients should understand before considering a compounded program.
Who actually prepares the medication
Compounded preparations vary from pharmacy to pharmacy. The integrity of any compounded medication ultimately depends on the practices of the specific pharmacy preparing it. Elara’s compounded preparations are prepared by a small number of independent partner pharmacies:
- RedRock Pharmacy — St. George, UT
- Health Warehouse — Florence, KY
- Precision Compounding Pharmacy — Bellmore, NY
- Triad Rx — Daphne, AL
All four hold active state pharmacy licenses, are regulated by their state boards of pharmacy, and meet USP standards for sterility and quality. We disclose them by name because patients should know exactly who is preparing their prescription.
Typical compounded tirzepatide pricing
Compounded tirzepatide programs through telehealth platforms generally range from $250 to $500 per month, depending on:
- The provider and what’s included in the price
- Your dose (higher doses sometimes cost more)
- Whether labs, clinician visits, and coaching are bundled or charged separately
- Whether you commit to a monthly, quarterly, or annual plan
The wide range matters. A “$250/month” headline price can quickly become $400+ once you add lab fees, follow-up consultation charges, and supplies that some providers leave out of their advertised rate.
Related reading: our full guide to compounded tirzepatide, plus Mounjaro for weight loss and Mounjaro side effects.
What’s included matters more than the headline price
This is where most cash-pay program comparisons fall apart. To evaluate a tirzepatide program fairly, you have to compare what’s actually included.
A bare-bones telehealth GLP-1 program typically includes the medication and an initial clinician consultation. That’s it. Everything else is either an add-on or simply not offered:
- Metabolic lab panels: typically $150 to $300 if you pay out of pocket through Quest or Labcorp
- Follow-up clinician visits: $50 to $150 each, often required quarterly
- Health coaching: not offered, or $100+ per month as an upgrade
- Injection supplies: usually included, but some providers charge separately
- Between-visit care team access: rarely included
Add those up, and a $250 “monthly price” can balloon to $450 or more in real annual costs. Many people don’t realize this until the second or third month.
Cost in context: a year of treatment
Tirzepatide treatment is typically continuous, so the right way to evaluate options is to look at total annual cost — including everything required for ongoing care — for each access path:
| Option | Monthly Cost | Annual Cost | What’s Included |
|---|---|---|---|
| Zepbound (retail, no insurance) | ~$1,060 | ~$12,720 | Medication only |
| Mounjaro (retail, no insurance) | ~$1,100+ | ~$13,200+ | Medication only |
| LillyDirect Zepbound vials | ~$349-$499 | ~$4,188-$5,988 | Medication only, self-administered from vial |
| Typical bare-bones compounded telehealth | ~$250-$500 | ~$3,000-$6,000 | Medication only; labs and coaching often extra |
| Elara Health & Wellness | $339/mo, or $267/mo billed annually | $3,204/yr on the annual plan | Medication, quarterly labs, regular coaching, ongoing clinician oversight, care team support |
Each row represents a different product or program with different inclusions and a different regulatory category. Brand-name Zepbound and Mounjaro are FDA-approved finished drug products manufactured by Eli Lilly. Compounded tirzepatide is a different regulatory category — 503A compounded preparations, prepared on a per-prescription basis, not FDA-approved as a finished drug product. The “right” choice isn’t determined by headline price alone but by what’s included, what your insurance actually covers, and what level of clinical support fits your situation.
What to look for in a compounded tirzepatide program
Not all compounded telehealth programs are equal. Before signing up with any provider, check for these markers of a legitimate operation:
Pharmacy disclosure. The program should disclose by name which compounding pharmacies prepare the medication, where they are located, and what state licensure or accreditation they hold. Programs that obscure their pharmacy partners are hiding the layer that matters most for the safety of any compounded preparation.
Pharmacy accreditation. Beyond state licensure, look for voluntary third-party accreditation like PCAB (Pharmacy Compounding Accreditation Board), which subjects the pharmacy to recurring inspections beyond minimum state requirements.
Board-certified physicians. The platform should connect you with physicians licensed in your state. Ask whether the physicians are board-certified and whether you can see who is prescribing your medication.
Real labs, not skipped labs. A reputable program requires a metabolic panel before prescribing and quarterly labs to monitor your progress. Programs that skip labs entirely are cutting a corner that matters for your safety.
Transparent pricing. Everything you’ll pay should be disclosed upfront, including any add-on fees. If the pricing page hides labs, follow-ups, or supplies behind asterisks, that’s a warning sign.
Ongoing care, not a one-time prescription. Tirzepatide requires dose adjustments, side effect management, and progress monitoring. A program that gives you a prescription and disappears isn’t providing real medical care.
Physical address and entity disclosure. A legitimate telehealth company will tell you who they are. Look for the legal entity name, state of formation, and a physical address in the footer or legal pages.
Who should consider brand-name tirzepatide?
Brand-name Zepbound or Mounjaro generally makes more sense if:
- You have commercial insurance that covers the medication, bringing your out-of-pocket cost to $25 to $200 per month
- You qualify for Eli Lilly’s savings card with meaningful discounts
- You have clinical history that makes you and your physician prefer the FDA-approved finished drug product
- You prefer the convenience of a pre-filled auto-injector pen over drawing from a vial
If any of these apply, work with your insurance and your physician to access the brand-name medication. Don’t pay $1,000+ a month at retail when there are better paths available to you.
Who should consider compounded tirzepatide?
A compounded program may make sense if:
- You don’t have insurance, or your insurance doesn’t cover GLP-1 medications for weight loss
- You’ve been quoted $1,000+ per month for brand-name and that isn’t workable
- You qualify for tirzepatide based on a clinician’s evaluation
- You want a program that includes labs, clinician oversight, and ongoing care without separate billing
- You understand and are comfortable with a 503A-compounded preparation that is not FDA-approved as a finished drug product
For cash-pay patients, the core question isn’t “drug A vs drug B” — it’s “given my insurance situation and what level of clinical support I need, what’s the right total cost of care?” Many patients in compounded programs also pair their treatment with a GLP-1 Support Pack to address common nutrient gaps that can occur during rapid weight loss.
How Elara’s tirzepatide program works
At Elara, every tirzepatide subscription includes:
- Compounded tirzepatide prepared by one of our four partner 503A pharmacies (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, or Triad Rx)
- Board-certified clinician oversight through our telehealth partner OpenLoop Health, with telehealth visits and ongoing protocol adjustments
- Quarterly metabolic lab panels at Quest Diagnostics or Labcorp, included at no additional cost
- A dedicated health coach who meets with you regularly to support nutrition, fitness, and treatment milestones
- Direct care team support for questions or concerns at (659) 208-7272 or support@elarahealthandwellness.com
- Direct medication delivery to your door each month
Pricing starts from $267 per month on our annual plan. See our full pricing breakdown or learn more about how the program works. There are no hidden fees, no separate lab charges, and no surprise bills.
The Elara program is available in all 50 states + DC, subject to change. Clinical services are provided by licensed clinicians through our telehealth partner OpenLoop Health.
Learn more about the Elara tirzepatide program →
Frequently asked questions
How does compounded tirzepatide differ from Zepbound or Mounjaro? Zepbound and Mounjaro are FDA-approved finished drug products manufactured by Eli Lilly. Compounded tirzepatide is prepared on a per-prescription basis by a state-licensed 503A compounding pharmacy and is not FDA-approved as a finished drug product. They sit in different regulatory categories with different oversight frameworks.
Why is compounded tirzepatide priced lower than brand-name? The pricing difference reflects different cost structures. Brand-name pricing includes pharmaceutical R&D, FDA pre-market approval, large-scale manufacturing, branded marketing, and PBM rebate negotiations. Compounded pricing reflects per-prescription preparation costs and clinical oversight overhead.
Is compounded tirzepatide safe? The safety of any compounded preparation depends on three layers: the pharmacy preparing it, the clinician prescribing it, and the program managing follow-up. Look for pharmacies with active state licensure and voluntary third-party accreditation (such as PCAB), clinician oversight by board-certified providers, and ongoing lab monitoring as the key markers.
Will my insurance cover compounded tirzepatide? Generally no. Most insurance plans don’t cover compounded medications. This is why compounded programs operate on a transparent cash-pay model rather than billing through insurance.
How long does it take to see results on tirzepatide? Outcomes vary by individual and depend on dose, lifestyle, and adherence. Your prescribing clinician will adjust your protocol based on your response and lab findings. Discuss expectations with your care team.
Can I switch from brand-name to a compounded program? Yes, many cash-pay patients do this for cost reasons. A licensed clinician will review your medical history and current dose to create an appropriate protocol. Don’t switch without clinician guidance.
The bottom line
Tirzepatide doesn’t have to cost over $1,000 a month for cash-pay patients. A 503A-compounded preparation through a legitimate, clinician-supervised program can deliver clinical care at significantly lower out-of-pocket cost than brand-name retail without insurance.
The key is choosing a program that includes everything you actually need — clinician oversight, labs, and ongoing care — at a transparent price, rather than chasing the lowest headline number and getting hit with add-on fees.
If you want to see whether you’d be a candidate for the Elara compounded tirzepatide program, take our free 5-minute clinical assessment. A licensed clinician will review your profile within 24 hours.
Learn more about our tirzepatide program →
Compounded tirzepatide is prepared by a state-licensed 503A compounding pharmacy under state pharmacy board oversight, pursuant to a patient-specific prescription issued by a licensed clinician following clinical evaluation. It is not FDA-approved as a finished drug product. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company; mentions here are informational and do not imply affiliation, endorsement, or therapeutic equivalence. The Elara program operates in all 50 states + DC, subject to change. Pricing referenced reflects publicly available information as of April 2026 and is subject to change. This article is for informational purposes only and is not a substitute for professional medical advice. Outcomes vary.